Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Silexion Therapeutics Corp | 27,889 | reported | 26 Mar 2026 | tx 2+49,726−22,818 |
| Foamix Pharmaceuticals Ltd. | 15,000 | reported | 27 Feb 2018 | tx 6+23,307−3,307 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Mar 2026 | SALE | Silexion Therapeutics Corp | 22,818 | 1.36 USD | |
| 20 Feb 2026 | GRANT_AWARD | Silexion Therapeutics Corp | 49,726 | 0.00 USD | |
| 27 Feb 2018 | GRANT_AWARD | Foamix Pharmaceuticals Ltd. | 5,000 | 0.00 USD | |
| 27 Feb 2018 | GRANT_AWARD | Foamix Pharmaceuticals Ltd. | 15,000 | 6.40 USD | deriv |
| 01 Jan 2018 | EXERCISE | Foamix Pharmaceuticals Ltd. | 2,745 | 0.00 USD | |
| 15 Jan 2018 | EXERCISE | Foamix Pharmaceuticals Ltd. | 562 | 0.00 USD | |
| 01 Jan 2018 | EXERCISE | Foamix Pharmaceuticals Ltd. | 2,745 | 0.00 USD | deriv |
| 15 Jan 2018 | EXERCISE | Foamix Pharmaceuticals Ltd. | 562 | 0.00 USD | deriv |